ChromaDex, Inc.
10005 Muirlands Boulevard
Suite G, First Floor
Irvine
California
92618
United States
Tel: 949-419-0288
Fax: 949-419-0294
Website: http://www.chromadex.com/
Email: custsvc@chromadex.com
247 articles about ChromaDex, Inc.
-
ChromaDex, Inc. Announces the Award of Two Method Validation Study Contracts From the Office of Dietary Supplements, National Institutes of Health
10/29/2012
-
Phenomenex, Inc. and ChromaDex, Inc. to Collaborate on Reference Standards Solutions for Dietary Supplements
9/27/2012
-
ChromaDex, Inc. to Present at the 2012 Gateway Conference on September 6
8/31/2012
-
Human Clinical Efficacy Data for ChromaDex, Inc.'s Patented pTeroPure® (pterostilbene) to be Presented at American Heart Association's High Blood Pressure Research 2012 Scientific Sessions
8/9/2012
-
ChromaDex, Inc. Announces Financial Results for the Second Quarter 2012
8/9/2012
-
ChromaDex, Inc. Licenses Exclusive Patent Rights for Nicotinamide Riboside (NR) Vitamin Technologies from Dartmouth College
7/16/2012
-
Clinical Safety Data for ChromaDex, Inc.'s Patented pTeroPure® (pterostilbene) Released at 6th World Congress on Polyphenols Applications in Paris
6/13/2012
-
ChromaDex, Inc. and The Scripps Research Institute Collaborate on METLIN Metabolite Database
5/31/2012
-
ChromaDex, Inc. Experiencing Higher Than Expected Demand for Its Recently Launched BluScience(TM) Line of Dietary Supplements
5/17/2012
-
ChromaDex, Inc. Announces Financial Results for the First Quarter 2012
5/11/2012
-
ChromaDex, Inc. and Platinum Performance(R) Collaborate on Development of Platinum Longevity(TM), an Equine Supplement Featuring the Novel Ingredient pTeroGold(TM)
4/2/2012
-
ChromaDex, Inc.'s Founder, Frank Jaksch, Appears as an Industry Expert on "Dateline NBC"
3/19/2012
-
ChromaDex, Inc. Announces Financial Results for the Year Ended 2011
3/15/2012
-
ChromaDex, Inc. Names Debra Heim as COO
2/21/2012
-
ChromaDex, Inc. Announces Management Changes
2/21/2012
-
Opko Health, Inc. Invests in ChromaDex, Inc.
2/16/2012
-
Opko Health, Inc. Invests in ChromaDex, Inc.
2/16/2012
-
ChromaDex, Inc. Announces the Closing of Common Stock Sale with Gross Proceeds of $11.175 Million
2/13/2012
-
ChromaDex, Inc. Announces Expanded Retail Distribution for its BluScience(TM) Line of Dietary Supplements at a National Drug Store Chain
1/10/2012
-
ChromaDex, Inc. Announces Successful Completion of Patient Enrollment for the First Human Clinical Study of its Proprietary pTeroPure(R)
12/16/2011